First Bundibugyo Vaccine Trial Begins in Congo as Uganda Bars Transit for Recent Congo Travelers
Saturday, October 24, 2026 · 5 min
The Tumaini Phase 2/3 trial vaccinated its first participant in Bunia on Friday, starting with Ervebo, as WHO counts 9,704 confirmed cases in Congo. Uganda halts transit for travelers recently in Congo while Switzerland disputes Uganda's account of the Nigeria patient's travel.
Listen
Show notes
The Tumaini Phase 2/3 trial vaccinated its first participant in Bunia on Friday, starting with Ervebo, as WHO counts 9,704 confirmed cases in Congo. Uganda halts transit for travelers recently in Congo while Switzerland disputes Uganda's account of the Nigeria patient's travel.
In this episode
- First participant vaccinated in pivotal Phase 2/3 Bundibugyo vaccine trial in DRC | Institute of Tropical Medicine — Institute of Tropical Medicine
“There is still no licensed vaccine against Bundibugyo virus, and the cost of that absence is being counted in the DRC every day, in lives lost and in health workers who go to work without protection.”
- Ebola: Uganda restricts border transit, reinstates locator forms | Monitor — Monitor Reporter
“As part of the strict border measures, travellers with a recent history of travel to the Democratic Republic of the Congo (DRC) will temporarily not be permitted to transit through Uganda.”